Abbonarsi

The challenge of sustainability: Long-term results from the Fifty-Fifty peer group-based intervention in cardiovascular risk factors - 26/09/21

Doi : 10.1016/j.ahj.2021.06.006 
Juan Miguel Fernández-Alvira, PhD a, Rodrigo Fernández-Jiménez, MD, PhD a, b, , Mercedes de Miguel, MSc a, c, Gloria Santos-Beneit, PhD a, c, d, Patricia Bodega, MsC a, c, Christopher A Hill, BA d, Vanesa Carral, PhD c, Carla Rodríguez, MSc c, Isabel Carvajal, MSc c, Xavier Orrit, PhD c, Amaya de Cos-Gandoy, MsC a, c, Marian Dal Re, BSc e, Teresa Robledo, MD e, Valentín Fuster, MD, PhD a, c, d,
a Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain 
b Hospital Universitario Clínico San Carlos, Madrid, Spain 
c Foundation for Science, Health and Education (SHE), Barcelona, Spain 
d The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY 
e Spanish Agency for Food Safety and Nutrition (AESAN), Madrid, Spain 

Reprint requests: Rodrigo Fernández-Jiménez, MD, PhD. Centro Nacional de Investigaciones Cardiovasculares (CNIC), & The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai. 1 Gustave L Levy Pl. New York, NY 10029, USA.Centro Nacional de Investigaciones Cardiovasculares (CNIC), & The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai1 Gustave L Levy PlNew York, NY10029USA⁎⁎Reprint requests: Valentin Fuster, MD, PhD. Centro Nacional de Investigaciones Cardiovasculares (CNIC), The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai. 1 Gustave L Levy Pl. New York, NY 10029Centro Nacional de Investigaciones Cardiovasculares (CNIC)The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai1 Gustave L Levy PlNew YorkNY10029

Riassunto

Background

The Fifty-Fifty trial demonstrated that a peer-group-based intervention was able to improve healthy behaviors in individuals with cardiovascular (CV) risk factors immediately post-intervention.

Objectives

To determine the long-term sustainability of a one-year peer-group-based intervention focused on CV health and behavior.

Methods

A total of 543 adults aged 25 to 50 years with at least 1 CV risk factor were screened and recruited, received initial training through workshops, and were then randomized 1:1 to a peer-group–based intervention group (IG) or a self-management control group (CG) for 12 months. At a median of 52 months from baseline, 321 participants were re-assessed (~60% retention). The primary outcome was the mean change in a composite health score related to blood pressure, exercise, weight, alimentation, and tobacco use (Fuster-BEWAT score [FBS], range 0-15). Intervention effects were assessed using linear-mixed effects models.

Results

The mean age of retained participants was 48.0 years (SD: 5.4), and 73% were female. Consistent with previous results, the change of overall FBS was significantly greater in the IG than in the CG at 12-month follow-up (between-group difference, 0.60 points; 95% CI, 0.08-1.12; P = .025). Assessment of long-term sustainability (52-month follow-up) showed that there were no between-group differences in the mean overall FBS (IG mean score, 8.52; 95% CI, 7.97-9.07 vs CG mean score, 8.51; 95% CI, 7.93-9.10; P = .972) or in the change of overall FBS from screening (IG mean change, 0.64; 95% CI, 0.00-1.28; CG mean change, 0.46; 95% CI, -0.20-1.12; P = .497).

Conclusions

A one-year peer-group-based intervention showed favorable results at immediate post-intervention but did not demonstrate significant differences between the IG and CG at 52 months. Combination of an initial training period (workshops) with the maintenance of peer-support groups or other re-intervention strategies may be required to achieve sustained effects on healthy behaviors.

Trial registration

ClinicalTrials.gov identifier NCT02367963. Registered (NCT02367963).

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2021  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 240

P. 81-88 - Ottobre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
  • Gad Cotter, Beth A. Davison, Christopher Edwards, Stefanie Senger, John R. Teerlink, Faiez Zannad, Olav Wendelboe Nielsen, Marco Metra, Alexandre Mebazaa, Ovidiu Chioncel, Barry H Greenberg, Aldo P Maggioni, Georg Ertl, Naoki Sato, Alain Cohen-Solal
| Articolo seguente Articolo seguente
  • Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy
  • Mitsuru Abe, Yukio Ozaki, Hiroshi Takahashi, Mitsuru Ishii, Nobutoyo Masunaga, Tevfik F. Ismail, Satoshi Iimuro, Retsu Fujita, Hiroshi Iwata, Ichiro Sakuma, Yoshihisa Nakagawa, Kiyoshi Hibi, Takafumi Hiro, Yoshihiro Fukumoto, Seiji Hokimoto, Katsumi Miyauchi, Hisao Ogawa, Hiroyuki Daida, Hiroaki Shimokawa, Yasushi Saito, Masunori Matsuzaki, Masaharu Akao, Takeshi Kimura, Ryozo Nagai

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.